Mangoceuticals, Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Mangoceuticals, Common Stock
MGRX Stock   3.64  0.27  6.91%   
Mangoceuticals, Common financial statements provide useful quarterly and yearly information to potential Mangoceuticals, Common Stock investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mangoceuticals, Common financial statements helps investors assess Mangoceuticals, Common's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mangoceuticals, Common's valuation are summarized below:
Gross Profit
442.4 K
Market Capitalization
18.1 M
Enterprise Value Revenue
24.2141
Revenue
755 K
Earnings Share
(5.70)
We have found eighty-six available fundamental ratios for Mangoceuticals, Common, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Mangoceuticals, Common last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Mangoceuticals, Common Total Revenue

883,278

Check Mangoceuticals, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.4 K, Interest Expense of 0.0 or Selling General Administrative of 7.8 M, as well as many indicators such as Price To Sales Ratio of 8.85, Dividend Yield of 0.0 or PTB Ratio of 7.23. Mangoceuticals, financial statements analysis is a perfect complement when working with Mangoceuticals, Common Valuation or Volatility modules.
  
Check out the analysis of Mangoceuticals, Common Correlation against competitors.

Mangoceuticals, Common Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets761.4 K1.2 M268.4 K
Slightly volatile
Short and Long Term Debt Total191 K148 K80.7 K
Slightly volatile
Total Current Liabilities187.3 K242.7 K85.8 K
Slightly volatile
Cash529.6 K849.9 K192 K
Slightly volatile
Cash And Short Term Investments529.6 K849.9 K192 K
Slightly volatile
Common Stock Shares Outstanding1.2 M1.3 M14.3 M
Slightly volatile
Liabilities And Stockholders Equity761.4 K1.2 M268.4 K
Slightly volatile
Other Stockholder Equity14.5 M13.8 M2.7 M
Slightly volatile
Total Liabilities258.3 K317.4 K107 K
Slightly volatile
Net Invested Capital578.9 K891 K206 K
Slightly volatile
Short and Long Term Debt113.7 K192.6 K69.5 K
Slightly volatile
Total Current Assets563.1 K941.2 K205.5 K
Slightly volatile
Capital Stock1.6 K2.5 K1.1 K
Slightly volatile
Short Term Debt120 K73.3 K59.5 K
Slightly volatile
Common Stock1.6 K2.5 K1.1 K
Slightly volatile
Accounts Payable95.9 K161.9 K52.3 K
Slightly volatile
Non Currrent Assets Other13.6 K15.2 K16.6 K
Slightly volatile
Other Assets13.6 K15.2 K16.6 K
Slightly volatile
Other Current Assets40 K70.1 K20.2 K
Slightly volatile
Property Plant Equipment233.4 K262.6 K286.3 K
Slightly volatile

Mangoceuticals, Common Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization26.4 K22.4 K57.4 K
Slightly volatile
Selling General Administrative7.8 M7.4 M1.5 M
Slightly volatile
Selling And Marketing Expenses2.5 M2.4 M501.6 K
Slightly volatile
Other Operating Expenses12 M11.4 M2.2 M
Slightly volatile
Total Operating Expenses11.7 M11.1 M2.2 M
Slightly volatile
Total Revenue883.3 K841.2 K160.8 K
Slightly volatile
Gross Profit521 K496.2 K94.5 K
Slightly volatile
Cost Of Revenue362.2 K345 K66.3 K
Slightly volatile
Reconciled Depreciation14.5 K25.8 K7.1 K
Slightly volatile

Mangoceuticals, Common Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash61.3 K64.6 K69.6 K
Slightly volatile
Net Borrowings82.8 K44.9 K132 K
Slightly volatile
Depreciation30.1 K28.6 K8.4 K
Slightly volatile
Other Non Cash Items1.8 M1.8 M354.1 K
Slightly volatile
Capital Expenditures3 K3.2 K35.6 K
Slightly volatile
Total Cash From Financing Activities8.5 M8.1 M1.6 M
Slightly volatile
End Period Cash Flow529.6 K849.9 K192 K
Slightly volatile
Change To Netincome759.3 K723.1 K171.8 K
Slightly volatile
Stock Based Compensation472.2 K718.1 K303.6 K
Slightly volatile
Change In Working Capital33.2 K47.7 K23 K
Slightly volatile
Begin Period Cash Flow824.6 K785.3 K161.6 K
Slightly volatile
Issuance Of Capital Stock4.1 M6.3 M2.6 M
Slightly volatile
Change To Account Receivables44 K49.5 K53.9 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.859.3294.4 K
Slightly volatile
Average Payables13.5 K15.2 K16.5 K
Slightly volatile
Stock Based Compensation To Revenue0.930.9821.4499
Slightly volatile
Capex To Depreciation0.150.169.0938
Slightly volatile
EV To Sales7.948.3694.4 K
Slightly volatile
Inventory Turnover12.9714.5915.9105
Slightly volatile
Days Of Inventory On Hand18.0120.2622.0883
Slightly volatile
Payables Turnover2.011.920.4775
Slightly volatile
Sales General And Administrative To Revenue9.6410.14183
Slightly volatile
Average Inventory7.4 K8.3 K9.1 K
Slightly volatile
Capex To Revenue0.00530.00553.9187
Slightly volatile
Cash Per Share0.490.470.0958
Slightly volatile
Days Payables Outstanding1871972.5 K
Slightly volatile
Income Quality0.890.870.9419
Slightly volatile
Net Debt To EBITDA0.07260.07640.2624
Slightly volatile
Current Ratio1.93.491.1765
Slightly volatile
Capex Per Share0.00270.00280.0025
Slightly volatile
Revenue Per Share0.480.460.0912
Slightly volatile
Interest Debt Per Share0.08520.08110.019
Slightly volatile
Debt To Assets0.130.141.3526
Slightly volatile
Operating Cycle18.0120.2622.0883
Slightly volatile
Days Of Payables Outstanding1871972.5 K
Slightly volatile
Ebt Per Ebit1.11.151.0235
Slightly volatile
Effective Tax Rate0.120.132.999
Slightly volatile
Total Debt To Capitalization0.160.14241.3578
Slightly volatile
Quick Ratio1.873.411.1641
Slightly volatile
Cash Ratio1.783.151.1214
Slightly volatile
Days Of Inventory Outstanding18.0120.2622.0883
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.0429
Slightly volatile
Fixed Asset Turnover3.213.060.629
Slightly volatile
Debt Ratio0.130.141.3526
Slightly volatile
Price Sales Ratio8.859.3294.4 K
Slightly volatile
Asset Turnover0.660.630.1314
Slightly volatile
Gross Profit Margin0.460.530.5396
Pretty Stable

Mangoceuticals, Common Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.7 M5.3 M5.8 M
Slightly volatile
Enterprise Value4.3 M4.8 M5.2 M
Slightly volatile

Mangoceuticals, Fundamental Market Drivers

Cash And Short Term Investments739 K

Mangoceuticals, Upcoming Events

26th of January 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Mangoceuticals, Common Financial Statements

Mangoceuticals, Common investors use historical fundamental indicators, such as Mangoceuticals, Common's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals, Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue841.2 K883.3 K
Cost Of Revenue345 K362.2 K
Stock Based Compensation To Revenue 0.98  0.93 
Sales General And Administrative To Revenue 10.14  9.64 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.46  0.48 
Ebit Per Revenue(11.34)(11.91)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Mangoceuticals, Stock Analysis

When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY